• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终生情绪障碍与共病焦虑和物质使用障碍的时间顺序——来自荷兰心理健康调查与发病率研究的结果

Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.

作者信息

de Graaf R, Bijl R V, Spijker J, Beekman A T F, Vollebergh W A M

机构信息

Monitoring and Epidemiology Department, Netherlands Institute of Mental Health and Addiction, P. O. Box 725, 3500 AS Utrecht, The Netherlands.

出版信息

Soc Psychiatry Psychiatr Epidemiol. 2003 Jan;38(1):1-11. doi: 10.1007/s00127-003-0597-4.

DOI:10.1007/s00127-003-0597-4
PMID:12563553
Abstract

BACKGROUND

Little is known about the temporal sequencing of psychiatric disorders. The aim of this study was to obtain insight into patterns of co-occurrence of DSM-III-R mood disorders in relation to anxiety and substance use disorders, their temporal sequencing and the sociodemographic and long-term vulnerability predictors of this temporal sequencing.

METHODS

Data are from the Netherlands Mental Health Survey and Incidence Study (NEMESIS), a psychiatric epidemiological study in a representative sample of 7,076 adults aged 18-64.

RESULTS

Of those who had ever experienced a mood disorder, 46 % of males and 57 % of females had a history of anxiety disorders, and 43 % and 15 % of substance use disorders. Mood disorders were associated with all anxiety and substance use disorders, except with alcohol abuse among males. In the majority of anxiety-comorbid cases, the mood disorder arose after the anxiety disorder; the pattern for substance use-comorbid disorders was more variable. Deviation from the usual sequence of major depression and anxiety disorders was more often seen among females, subjects with a higher educational level, subjects who experienced childhood parental divorce, and subjects who experienced childhood emotional neglect.

CONCLUSIONS

When comorbid with anxiety disorders, mood disorders clearly tend to be secondary. Few of the studied demographic factors, familial vulnerability factors and childhood life events predict the sequencing of mood disorders in relation to other disorders.

摘要

背景

关于精神障碍的时间顺序了解甚少。本研究的目的是深入了解《精神疾病诊断与统计手册》第三版修订本(DSM-III-R)中情绪障碍与焦虑和物质使用障碍共病的模式、它们的时间顺序以及这种时间顺序的社会人口统计学和长期易感性预测因素。

方法

数据来自荷兰精神健康调查与发病率研究(NEMESIS),这是一项对7076名18 - 64岁成年人的代表性样本进行的精神疾病流行病学研究。

结果

在曾经经历过情绪障碍的人群中,46%的男性和57%的女性有焦虑障碍病史,43%和15%有物质使用障碍病史。情绪障碍与所有焦虑和物质使用障碍相关,但男性中的酒精滥用除外。在大多数焦虑共病病例中,情绪障碍在焦虑障碍之后出现;物质使用共病障碍的模式则更具变异性。在女性、教育水平较高的受试者、童年时期父母离异的受试者以及童年时期经历过情感忽视的受试者中,更常出现与重度抑郁症和焦虑症通常顺序不同的情况。

结论

当与焦虑障碍共病时,情绪障碍显然往往是继发性的。所研究的人口统计学因素、家族易感性因素和童年生活事件中,很少有因素能预测情绪障碍与其他障碍相关的时间顺序。

相似文献

1
Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.终生情绪障碍与共病焦虑和物质使用障碍的时间顺序——来自荷兰心理健康调查与发病率研究的结果
Soc Psychiatry Psychiatr Epidemiol. 2003 Jan;38(1):1-11. doi: 10.1007/s00127-003-0597-4.
2
Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.共病的途径:在一项基于人群的纵向研究中,单纯情绪、焦虑和物质使用障碍向共病状态的转变。
J Affect Disord. 2004 Nov 1;82(3):461-7. doi: 10.1016/j.jad.2004.03.001.
3
Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.全国共病调查复制研究中美国老年人情绪、焦虑和物质使用障碍的患病率。
Am J Geriatr Psychiatry. 2009 Sep;17(9):769-81. doi: 10.1097/JGP.0b013e3181ad4f5a.
4
[Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].[共病物质使用对患有精神病性或心境障碍的受试者神经心理表现的影响]
Encephale. 2002 Mar-Apr;28(2):160-8.
5
Lifetime prevalence, correlates, and persistence of oppositional defiant disorder: results from the National Comorbidity Survey Replication.对立违抗障碍的终生患病率、相关因素及持续性:全国共病调查复制研究的结果
J Child Psychol Psychiatry. 2007 Jul;48(7):703-13. doi: 10.1111/j.1469-7610.2007.01733.x.
6
Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.《酒精及相关状况全国流行病学调查》中情绪障碍的酒精和药物自我药疗
J Affect Disord. 2009 Jun;115(3):367-75. doi: 10.1016/j.jad.2008.10.003. Epub 2008 Nov 11.
7
Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.美国《精神疾病诊断与统计手册》第四版(DSM-IV)中酒精使用障碍与特定药物使用障碍的共病情况:来自全国酒精及相关状况流行病学调查的结果
Drug Alcohol Depend. 2005 Oct 1;80(1):105-16. doi: 10.1016/j.drugalcdep.2005.03.009. Epub 2005 Apr 18.
8
[Psychiatric morbidity among adults in The Netherlands: the NEMESIS-Study. II. Prevalence of psychiatric disorders. Netherlands Mental Health Survey and Incidence Study].[荷兰成年人的精神疾病发病率:NEMESIS研究。II. 精神障碍患病率。荷兰心理健康调查与发病率研究]
Ned Tijdschr Geneeskd. 1997 Dec 13;141(50):2453-60.
9
Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study.情绪、焦虑和物质使用障碍12个月共病的风险因素:荷兰心理健康调查与发病率研究的结果
Am J Psychiatry. 2002 Apr;159(4):620-9. doi: 10.1176/appi.ajp.159.4.620.
10
Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions.美国12个月内情绪与焦虑障碍和人格障碍的共病情况:酒精及相关状况全国流行病学调查结果
J Psychiatr Res. 2005 Jan;39(1):1-9. doi: 10.1016/j.jpsychires.2004.05.004.

引用本文的文献

1
Gender differences in clinical correlates of glucose disturbance in patients with first-episode and drug-naïve major depressive disorder.首发且未用药的重度抑郁症患者血糖紊乱临床相关因素的性别差异
Eur Arch Psychiatry Clin Neurosci. 2025 Feb 25. doi: 10.1007/s00406-025-01980-7.
2
Cannabis Use and Trajectories of Depression and Stress Across the Prenatal Period.孕期大麻使用与抑郁和压力的发展轨迹
JAMA Netw Open. 2024 Dec 2;7(12):e2451597. doi: 10.1001/jamanetworkopen.2024.51597.
3
Gender differences in risk factors for suicide attempts among young, first-episode and drug-naive major depressive disorder patients with anxiety symptoms.
伴有焦虑症状的年轻首发且未使用过药物的重度抑郁症患者自杀未遂风险因素中的性别差异。
Front Psychiatry. 2024 Aug 8;15:1424103. doi: 10.3389/fpsyt.2024.1424103. eCollection 2024.
4
Gender differences in prevalence and clinical correlates of anxiety in first-episode and drug-naïve patients with major depressive disorder comorbid with metabolic syndrome.首发未用药的伴代谢综合征的重性抑郁障碍患者中,焦虑的性别差异及其与临床的相关性。
BMC Psychiatry. 2024 Feb 22;24(1):156. doi: 10.1186/s12888-024-05574-w.
5
Gender differences in the association between anxiety symptoms and thyroid hormones in young patients with first-episode and drug naïve major depressive disorder.首发且未用药的年轻重度抑郁症患者中焦虑症状与甲状腺激素之间关联的性别差异。
Front Psychiatry. 2023 Aug 29;14:1218551. doi: 10.3389/fpsyt.2023.1218551. eCollection 2023.
6
Cardiovascular risk assessment methods yield unequal risk predictions: a large cross-sectional study in psychiatric secondary care outpatients.心血管风险评估方法的风险预测结果存在差异:精神科二级保健门诊患者的一项大型横断面研究。
BMC Psychiatry. 2023 Jul 24;23(1):536. doi: 10.1186/s12888-023-05022-1.
7
Heterotypic and homotypic continuity in psychopathology: a narrative review.精神病理学中的异型和同型连续性:一项叙述性综述。
Front Psychol. 2023 Jun 15;14:1194249. doi: 10.3389/fpsyg.2023.1194249. eCollection 2023.
8
Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options.焦虑和抑郁中的肠道微生物群:揭示其关系及管理方案
Pharmaceuticals (Basel). 2023 Apr 9;16(4):565. doi: 10.3390/ph16040565.
9
Factors associated with anxiety disorder comorbidity.与焦虑障碍共病相关的因素。
J Affect Disord. 2023 Feb 15;323:280-291. doi: 10.1016/j.jad.2022.11.051. Epub 2022 Nov 26.
10
Self-reported mental health during the COVID-19 pandemic and its association with alcohol and cannabis use: a latent class analysis.在 COVID-19 大流行期间的自我报告心理健康状况及其与酒精和大麻使用的关联:潜在类别分析。
BMC Psychiatry. 2022 Apr 30;22(1):306. doi: 10.1186/s12888-022-03917-z.